A British scientist has developed innovative technology that is able to deliver drugs deep into the brain, which could aid treatment of neurological diseases including Parkinson’s and cancer. The technology was designed by Steven Gill, a professor of neurosurgery at the University of Bristol, and has shown encouraging results in its first controlled clinical trial.
In a first, neuroengineers from Columbia have created a system that translates thought into intelligible, recognizable speech. By monitoring someone’s brain activity, the ground-breaking technology can reconstruct the words a person hears with unprecedented clarity. This breakthrough, which harnesses the power of speech synthesizers and AI, could lead to new ways for computers to communicate
German scientists have built an artificial synapse from nanowires that is able to replicate functions of biological synapses. The component, which was developed by a team at Forschungszentrum Jülich and RWTH Aachen Universities, has the ability to save and process information and receive numerous signals in parallel, making it suited to bio-inspired “neuromorphic” processors in
Research conducted at King’s College London has revealed how blood inflammation affects the birth and death of brain cells, potentially offering insight for new treatment targets for antidepressants. Mounting evidence points to high levels of inflammation as vital biological abnormality leading to depression in at least one third of patients. Although, the new study offers
The human brain is protected by the near impermeable blood brain barrier, often referred to as a fortress that protects the brain but also prevents the treatment of brain diseases, including brain tumours. Dr Zaynah Maherally and her team at University of Portsmouth have developed a model that mimics this barrier, with has helped in